New Jersey S3897 mandates myeloma screening for male patients during annual physical exams.

New Jersey S3897 requires licensed health care professionals to include myeloma screening as part of annual physical examinations for male patients. Myeloma, a cancer of plasma cells, is more prevalent and deadly among men, particularly African-American men, according to the American Cancer Society. This act aims to address the higher incidence and death rates of myeloma in men by ensuring early detection through routine screenings.

New Jersey S3897 mandates myeloma screening for male patients during annual physical exams.

New Jersey S3897 requires licensed health care professionals to include myeloma screening as part of annual physical examinations for male patients. Myeloma, a cancer of plasma cells, is more prevalent and deadly among men, particularly African-American men, according to the American Cancer Society. This act aims to address the higher incidence and death rates of myeloma in men by ensuring early detection through routine screenings.